The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
The company experienced demand traction in October, while new products and capacity expansion will act as growth levers ...
Responsible Statecraft on MSN3 小时
How corporate, foreign influence creeps into Congress
Sue Mi Terry, a leading expert on the Korean Peninsula who held senior positions at prestigious think tanks like the Wilson ...
Three companies were removed from CSI, the Shariah index of the Chittagong Stock Exchange (CSE), with no new entries to the ...
The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...
Four artists have been selected to develop new Pennsylvania Wilds branded designs as part of the inaugural PA Wilds Artisan ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
The S Pen and 2-in-1 form factor are great for arty types, but keyboard woes let the Samsung Galaxy Book5 Pro 360 down ...
Lithuania passed legislation to limit the ability of Chinese inverter manufacturers to remotely access the country’s solar ...
Iberdrola Australia has signed PPAs with regional councils in New South Wales that will see energy sourced from a large-scale ...
NOVONIX (ASX:NVX,NASDAQ:NVX) announced on Sunday (November 10) that it has signed a binding offtake agreement with automotive ...
Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, Sanofi, and all insulin manufacturers to take urgent action to increase access ...